Here are four notes:
1. LDR has a market cap of $503.95 million.
2. The company’s stock has declined 58.1 percent since July 10, 2015, and it continues to trend down.
3. It has underperformed the S&P500 by 47.9 percent.
4. Out of 10 analysts covering LDR, 11 rate it “buy,” zero “sell,” while one rates it “hold.”
More articles on devices:
43 spine, orthopedic devices receive FDA 510(k) clearance in January
Foot and ankle market to reach $5.4B in 2020 — 4 insights
Wright Medical Group shares receive average price target of $28.11: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
